Bailong Chuangyuan(SH:605016) Huaan Securities·2025-10-15 14:23Investment Rating - The investment rating for the company is "Accumulate" (maintained) [1] Core Views - The company reported continuous growth in Q3 2025, with revenue reaching 969 million yuan, a year-on-year increase of 18.10%, and a net profit attributable to shareholders of 265 million yuan, up 44.93% year-on-year [5] - The company's third-quarter revenue was 319 million yuan, reflecting a year-on-year increase of 10.61% but a quarter-on-quarter decrease of 4.82% [5] - The growth in revenue and gross margin is attributed to capacity expansion and a decline in raw material prices, with significant contributions from the soluble dietary fiber and crystalline sugar projects launched in May 2024 [6] - The domestic market for D-alloheptulose has officially opened, allowing the company to leverage its technological and production advantages to capture new market opportunities [7] - The establishment of a production base in Thailand is expected to enhance cost efficiency and strengthen the company's competitive position in global markets [8][9] Financial Summary - The company expects net profits for 2025-2027 to be 338 million, 412 million, and 536 million yuan respectively, with corresponding P/E ratios of 25, 21, and 16 times [10] - Key financial indicators for 2025E include revenue of 1.421 billion yuan, a net profit of 338 million yuan, and a gross margin of 35.5% [11] - The company’s cash flow from operating activities is projected to be 263 million yuan in 2025E [14]